News Articles
Sector/Industry
Please Select
Company
24 October, 2024
Memphasys’ Felix™ Clinical Trial Nears Completion as CE Mark Strategy Speeds European Market Entry
Australian biotech company Memphasys Limited (ASX: MEM) is closing in on a key milestone with its Felix™ System clinical trial, which is now 90% complete. With fewer than 20 patients left to recruit,...
22 October, 2024
Adisyn Ltd (ASX: AI1) Powers Up: 2D Generation Acquisition Set to Supercharge AI Revolution
In a bold move, Adisyn Ltd (ASX: AI1) has shifted its relationship with Israeli graphene innovator 2D Generation (2DG) into high gear, announcing its proposed acquisition of the semiconductor IP...
18 October, 2024
MTM Critical Metals to Present at COSM Summit: Tech Giants to Witness E-Waste Revolution
MTM Critical Metals Ltd (ASX: MTM) has been invited to present its groundbreaking Flash Joule Heating (FJH) technology at the prestigious COSM Technology Summit in Seattle, USA. The event is a...
17 October, 2024
Memphasys Gears Up for Felix™ Commercialisation in the Equine Fertility Market
Memphasys Limited (ASX: MEM) is racing towards commercialising its Felix™ System, a technology designed to revolutionise the equine fertility market. Following promising initial trials, the company...
17 October, 2024
Little Green Pharma: Leading the Pack in Medicinal Cannabis Growth
Little Green Pharma (ASX: LGP) is on a roll, emerging as a standout player in the medicinal cannabis sector. Its latest quarterly report for September 2024 tells a compelling story of record...